FANCB (Fanconi Anemia Group B) encodes a critical component of the Fanconi anemia (FA) core complex, a multisubunit protein assembly essential for the FA DNA damage response pathway. Unlike most FA genes that are autosomal, FANCB is located on the X chromosome (Xq22.3), making it unique in the FA family. In males, a single mutation (hemizygous) results in complete loss of FANCB function, causing severe Fanconi anemia with early onset of bone marrow failure and developmental abnormalities. The FA pathway is crucial for resolving DNA interstrand crosslinks (ICLs), which are among the most cytotoxic forms of DNA damage. Beyond its well-established role in FA, emerging evidence suggests that FANCB and the FA pathway contribute to neuronal survival and may be relevant to neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.
| Property |
Value |
| Gene Symbol |
FANCB |
| Full Name |
Fanconi Anemia Group B |
| Chromosomal Location |
Xq22.3 |
| NCBI Gene ID |
63027 |
| OMIM |
300515 |
| Ensembl ID |
ENSG00000128590 |
| UniProt |
Q8TD96 |
| Protein Family |
Fanconi anemia core complex |
| Length |
859 amino acids |
The FA core complex is a multisubunit assembly comprising at least nine proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, and FAAP20). This complex serves as the "hub" of the FA pathway:
Core Complex Assembly:
- FANCB acts as a scaffold, binding directly to FANCA, FANCC, and FANCL
- FANCL contains the E3 ubiquitin ligase activity essential for downstream activation
- FANCM provides DNA binding capacity, anchoring the complex to ICL sites
- FAAP20 stabilizes the complex and connects to the Fanconi anemia-associated proteins
¶ DNA Interstrand Crosslink Repair
FANCB participates in the central mechanism of ICL repair:
- Damage detection: DNA ICLs block DNA replication and transcription
- Core complex recruitment: FANCB helps assemble the FA core at damage sites
- FANCD2 activation: The core complex monoubiquitinates FANCD2
- ** downstream repair**: Monoubiquitinated FANCD2 coordinates DNA repair proteins
- Resolution: Completed repair allows DNA replication to proceed
The ICL repair process involves multiple DNA repair pathways including:
- Nucleotide excision repair (NER)
- Homologous recombination (HR)
- Translesion synthesis (TLS)
- Fanconi anemia-specific factors
FANCB contains:
- N-terminal region: Protein interaction domains
- C-terminal region: Required for complex assembly
- Multiple protein-binding interfaces: Connects to FANCA, FANCC, FANCL
¶ DNA Damage and Neuronal Death
Neurons are particularly vulnerable to DNA damage due to their post-mitotic state and high metabolic activity. The FA pathway may protect neurons:
- Oxidative stress: Neurons accumulate oxidative DNA damage
- Repair capacity: The FA pathway contributes to DNA repair in neurons
- Aging: Age-related decline in FA pathway function may contribute to neurodegeneration
FANCB involvement in AD:
- Genomic instability: Increased DNA damage in AD brain
- FA pathway dysregulation: Altered FANCB expression in AD
- Oxidative stress: ROS-induced DNA damage in AD
- Neuronal vulnerability: Impaired DNA repair contributes to neuron loss
In PD, FANCB may be relevant through:
- Dopaminergic neuron sensitivity: High oxidative stress in substantia nigra
- Mitochondrial DNA damage: mtDNA lesions in PD
- Aging: Age-related decline in DNA repair capacity
- FANCD2 activation: Altered FA pathway in PD models
FANCB in ALS:
- DNA repair defects: Impaired DNA repair in ALS
- Motor neuron vulnerability: High metabolic demand increases DNA damage
- FA pathway alterations: Changed expression in ALS models
FANCB mutations cause X-linked Fanconi anemia, characterized by:
- Bone marrow failure: Pancytopenia, often severe in childhood
- Congenital anomalies: Radial ray defects, short stature, characteristic facial features
- Cancer predisposition: High risk of acute myeloid leukemia, solid tumors
- VACTERL association: Vertebral, anal, cardiac, tracheal, esophageal, renal, limb anomalies
- Growth and developmental delays: Multiple systems affected
FANCB inheritance pattern:
- X-linked recessive: Only males affected (hemizygous)
- Carrier females: Usually asymptomatic carriers
- De novo mutations: Common, no family history
- Variant severity: Null alleles most severe
- Genetic testing: FANCB sequencing confirms diagnosis
- Chromosomal breakage test: Sensitivity to diepoxybutane (DEB) or mitomycin C
- Fanconi anemia pathway analysis: FANCD2 monoubiquitination assay
FANCB is ubiquitously expressed:
- Highest: Testis, bone marrow, thymus
- Moderate: Most tissues including brain
- Low: Some peripheral tissues
- Proliferating cells: Highest expression in dividing cells
- Neurons: Lower but detectable expression
- Glial cells: Expressed in astrocytes and microglia
- Embryonic: Expression throughout development
- Adult: Maintained in most tissues
- Cell cycle: Upregulated during S phase
Current and emerging treatments:
- Androgen therapy: Historical treatment for bone marrow failure
- Hematopoietic stem cell transplantation: Curative for bone marrow failure
- Gene therapy: Experimental approaches to restore FANCB function
- Small molecule approaches: Enhancing FA pathway function
Potential applications for neurodegenerative diseases:
- DNA repair enhancement: Small molecules that boost FA pathway
- Antioxidant approaches: Reduce oxidative DNA damage
- Gene therapy: For specific neurological applications
FA pathway in cancer:
- Chemotherapy sensitivity: FA-deficient cells sensitive to crosslinking agents
- Therapeutic targeting: Cancer-selective therapies based on FA status
The FA pathway is triggered by DNA ICLs:
- Sensor: FANCM detects ICLs and recruits the core complex
- Assembly: Core complex (including FANCB) assembles at damage sites
- Activation: FANCL E3 ligase monoubiquitinates FANCD2
- Effector: FANCD2 recruits repair proteins to DNA
- Resolution: DNA repair completes, pathway resets
After FANCD2 activation:
- BRCA1/2: Homologous recombination proteins
- RAD51: Strand invasion and repair
- SLX4: Endonuclease complex
- ATR/Chk1: Cell cycle checkpoint
- BRCA network: FA and BRCA pathways intersect
- NER pathway: Core ICL repair machinery
- Cell cycle control: Checkpoint coordination
- Diagnostic testing: For suspected FA patients
- Carrier testing: For female relatives of FANCB patients
- Prenatal diagnosis: For families with known mutations
- FANCD2 monoubiquitination: Pathway activity measure
- Chromosomal breakage: Diagnostic sensitivity assay
- FANCB protein levels: Expression analysis
- FA severity: FANCB mutations generally cause severe phenotype
- Cancer risk: Lifelong monitoring required
- Treatment response: Variable, depends on specific mutation
Current research focuses on:
- Understanding FANCB structure and function
- Developing gene therapy approaches
- FA pathway in neurodegeneration
- Cancer prevention in FA patients
In cortex:
- DNA repair in neurons
- Age-related dysfunction
- Not well characterized
In hippocampus:
- Memory circuit DNA repair
- Neural stem cells
- AD links
In substantia nigra:
- Dopaminergic neurons
- PD relevance
- Vulnerability
In cerebellum:
- Purkinje cells
- Not primary focus
¶ FANCB and Protein Aggregation
In AD:
- DNA repair capacity
- Accumulated damage
In tauopathies:
In PD:
- DNA repair in immunity
- Not primary focus
¶ FANCB and Synaptic Function
- Synaptic proteins: Damage accumulation
- Repair mechanisms: Not well characterized
- Dysfunction: With age/disease
- Fancb knockout: Embryonic lethal
- Conditional: Tissue-specific
- DNA repair defects
- Cancer predisposition
¶ FANCB and Cellular Stress
- ROS-induced DNA damage
- FA pathway activation
- FA diagnosis
- Carrier detection
| Approach |
Status |
Indication |
| Gene therapy |
Research |
FA |
| DNA repair |
Preclinical |
Neurodegeneration |
- ICL repair
- Complementation
- Patient cells
- Gene editing